SAN DIEGO – Medtrade exhibitor ResMed Inc reported third quarter revenue of $514.2 million, a 13% increase compared to the same period last year. Excluding the contribution from the Brightree business acquired in April 2016, revenue for the quarter was $479.2 million, a 6% increase.    

“We had solid double-digit constant currency revenue growth in Q3, led by our Brightree software solutions as well as mask and device sales,” said Mick Farrell, ResMed’s CEO. “This quarter we saw strong demand for our new AirFit 20 range of masks. We also made significant progress on software innovation with the launch of enhanced integration capabilities with Brightree and our AirSolutions cloud-based software platform. In our current quarter, we are launching our latest market-leading innovation: the ResMed AirMini—the world’s smallest CPAP.”

AirMini packs ResMed’s clinically proven CPAP (continuous positive airway pressure) technology, along with its comfort and ease-of-use features, into a “portable, pocket-sized device ideal for traveling.” According to company officials, the AirMini is available with ResMed’s proprietary AutoSet™ functionality as well as a built-in humidification system for patient comfort. AirMini weighs 0.66 pounds (300 grams) and measures 5.4 x 3.3 x 2 in (13.6 x 8.4 x 5.2 cm).

ResMed will take preorders from HMEs beginning on May 3, 2017, and AirMini will begin shipping by May 31. It will also be available at initial launch in Australia, Canada, Denmark, Finland, Germany, New Zealand, Spain and the United Kingdom, with other countries to follow. “We typically showcase all our current products at Medtrade,” said company officials. “Although it’s early in our planning process for October’s event [scheduled for Oct 23-26 at the Georgia World Congress Center in Atlanta], we expect AirMini will be featured in our booth at the show.”